"At Allergy Partners, we strive to be recognized as leaders in the development and delivery of high-quality health care for patients with asthma and allergic disease. Our vast care network of providers work together to promote education, research & innovation in the field of allergy & asthma care."

During the past decade, Allergy Partners of North Texas Research conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Allergy Partners of North Texas Research" #1 sponsor was "Green Cross Corporation" with 2 trials, followed by "Aimmune Therapeutics, Inc." with 1 trials sponsored, "Baxalta now part of Shire" with 1 trials sponsored, "COUR Pharmaceutical Development Company, Inc." with 1 trials sponsored and "Grifols Therapeutics LLC" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Allergy Partners of North Texas Research" #1 collaborator was "Atlantic Research Group" with 2 trials as a collaborator, "Baxalta Innovations GmbH, now part of Shire" with 1 trials as a collaborator and "Parexel" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Allergy Partners of North Texas Research" are "Peanut Allergy" (2 trials), "Immunologic Deficiency Syndromes" (1 trials), "Primary Immune Deficiency" (1 trials), "Primary Immunodeficiency" (1 trials) and "Primary Immunodeficiency Disease" (1 trials). Many other conditions were trialed in "Allergy Partners of North Texas Research" in a lesser frequency.

Most popular intervention types in "Allergy Partners of North Texas Research" are "Biological" (6 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "GC5107" (2 trials), "AR101 powder provided in capsules & sachets" (1 trials), "CNP-201" (1 trials), "GAMMAGARD LIQUID" (1 trials) and "Gamunex-C" (1 trials). Other intervention names were less common.

The vast majority of trials in "Allergy Partners of North Texas Research" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Allergy Partners of North Texas Research". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Allergy Partners of North Texas Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Allergy Partners of North Texas Research, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".